Researchers Find That Long-COVID Prevalence Decreases as Acute Illness Becomes Milder

Long-COVID is a common complication of infection with severe acute respiratory syndrome coronavirus 2, but the prevalence and predictors of the condition remain poorly characterized, say Figueroa, et al. (2025).

The researchers prospectively studied adults (≥18 years) with acute coronavirus disease 2019 (COVID-19) presenting to an urban safety net hospital and associated clinics between July 2020 and December 2022. Logistic regression models were used to evaluate the association between baseline demographic, clinical, and laboratory characteristics with long-COVID status, defined as symptoms persisting at least 9 months after acute disease. Among unrecovered participants, the researchers describe the prevalence of individual symptoms.

222 participants were enrolled, 162 (73%) of whom had known recovery status by 9 months. Median age was 54 years, half (55%) were female, and the majority of participants (78%) had at least 1 comorbidity at the time of COVID-19 diagnosis. Based on acute illness characteristics, the adjusted odds ratio for long COVID was 3.0 (95% confidence interval [CI], 1.1–8.0) among those with detectable nucleocapsid antigen and 3.6 (95% CI, 1.2–11) for those who required supplemental oxygen. Of the 41% of participants with symptoms persisting at least 9 months, central nervous system and psychological symptoms were most commonly reported, with 57% reporting functional limitations due to their persistent symptoms.

The researchers conclude that the strong association with initial disease suggests a decreasing prevalence of long-COVID as acute illnesses become milder. However, many contemporary patients still experience high viral burden with extended viral replication, even after vaccination. They say their findings highlight the importance of properly characterizing long-COVID as viral evolution shifts acute disease presentation.

Reference: Figueroa EB, et al. Viral Burden and Illness Severity During Acute SARS-CoV-2 Infection Predict Persistent Long COVID Symptoms. Open Forum Infectious Diseases, Volume 12, Issue 2, February 2025, ofaf048, https://doi.org/10.1093/ofid/ofaf048